المؤلفون: Caicun Zhou, MD, PhD, You Lu, MD, Sang-We Kim, MD, PhD, Thanyanan Reungwetwattana, MD, Jianying Zhou, MD, Yiping Zhang, MD, Jianxing He, MD, PhD, Jin-Ji Yang, MD, Ying Cheng, MD, Se-Hoon Lee, MD, PhD, Jianhua Chang, MD, Jian Fang, MD, Zhe Liu, PhD, Lilian Bu, MSc, Li Qian, MD, Tingting Xu, MD, Venice Archer, MB ChB, MSc, Magalie Hilton, MSc, Mingzhu Zhou, MSc, Li Zhang, MD

المصدر: JTO Clinical and Research Reports, Vol 5, Iss 9, Pp 100700- (2024)

مصطلحات موضوعية: ALESIA, Alectinib, ALK, Crizotinib, NSCLC, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2666364324000705; https://doaj.org/toc/2666-3643

URL الوصول: https://doaj.org/article/0adb5b401a534eba8c323105cdaa5a38